OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Aberrant lipid metabolism in cancer cells and tumor microenvironment: the player rather than bystander in cancer progression and metastasis
YU Xiu-jing, Shuyi Mi, Jun Ye, et al.
Journal of Cancer (2021) Vol. 12, Iss. 24, pp. 7498-7506
Open Access | Times Cited: 13
YU Xiu-jing, Shuyi Mi, Jun Ye, et al.
Journal of Cancer (2021) Vol. 12, Iss. 24, pp. 7498-7506
Open Access | Times Cited: 13
Showing 13 citing articles:
Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer
Kamal Eltayeb, Silvia La Monica, Marcello Tiseo, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 413-413
Open Access | Times Cited: 49
Kamal Eltayeb, Silvia La Monica, Marcello Tiseo, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 413-413
Open Access | Times Cited: 49
Luteolin, a flavone ingredient: Anticancer mechanisms, combined medication strategy, pharmacokinetics, clinical trials, and pharmaceutical researches
Mingyi Shi, Zixian Chen, Hui Gong, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 2, pp. 880-911
Closed Access | Times Cited: 23
Mingyi Shi, Zixian Chen, Hui Gong, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 2, pp. 880-911
Closed Access | Times Cited: 23
Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways
Fahad Khan, Deena Elsori, Meenakshi Verma, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Fahad Khan, Deena Elsori, Meenakshi Verma, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
FASN inhibition shows the potential for enhancing radiotherapy outcomes by targeting glycolysis, AKT, and ERK pathways in breast cancer
Ching-I Chen, Deng-Yu Kuo, Hui-Yen Chuang
International Journal of Radiation Biology (2025), pp. 1-12
Open Access
Ching-I Chen, Deng-Yu Kuo, Hui-Yen Chuang
International Journal of Radiation Biology (2025), pp. 1-12
Open Access
Unveiling the MUFA–Cancer Connection: Insights from Endogenous and Exogenous Perspectives
Zhiqiang Guo, Karl‐F. Bergeron, Marine Lingrand, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9921-9921
Open Access | Times Cited: 13
Zhiqiang Guo, Karl‐F. Bergeron, Marine Lingrand, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9921-9921
Open Access | Times Cited: 13
Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease
Tongguo Miao, Xian-zhe Lou, Shiming Dong, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 145-157
Open Access | Times Cited: 4
Tongguo Miao, Xian-zhe Lou, Shiming Dong, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 145-157
Open Access | Times Cited: 4
The Role of the Dysregulation of circRNAs Expression in Glioblastoma Multiforme
Yafei Wang, Ying Yu, Jiahua Yu, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 1
Closed Access
Yafei Wang, Ying Yu, Jiahua Yu, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 1
Closed Access
PLD2 is a marker for MASLD-HCC with early-stage fibrosis: revealed by lipidomic and gene expression analysis
Jihan Sun, Fatima Dahboul, Estelle Pujos‐Guillot, et al.
Metabolomics (2025) Vol. 21, Iss. 2
Closed Access
Jihan Sun, Fatima Dahboul, Estelle Pujos‐Guillot, et al.
Metabolomics (2025) Vol. 21, Iss. 2
Closed Access
Steatosis in metabolic diseases: A focus on lipolysis and lipophagy
Xingtao Zhao, Felix Kwame Amevor, Zhifu Cui, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114311-114311
Open Access | Times Cited: 11
Xingtao Zhao, Felix Kwame Amevor, Zhifu Cui, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114311-114311
Open Access | Times Cited: 11
Fatostatin promotes anti-tumor immunity by reducing SREBP2 mediated cholesterol metabolism in tumor-infiltrating T lymphocytes
L. F. Zhu, Yilin Shi, Zhelong Feng, et al.
European Journal of Pharmacology (2024) Vol. 971, pp. 176519-176519
Open Access | Times Cited: 3
L. F. Zhu, Yilin Shi, Zhelong Feng, et al.
European Journal of Pharmacology (2024) Vol. 971, pp. 176519-176519
Open Access | Times Cited: 3
Double C-2 like domain beta (DOC2B) induces calcium dependent oxidative stress to promote lipotoxicity and mitochondrial dysfunction for its tumor suppressive function
Divya Adiga, Samatha Bhat, Vaibhav Shukla, et al.
Free Radical Biology and Medicine (2023) Vol. 201, pp. 1-13
Closed Access | Times Cited: 7
Divya Adiga, Samatha Bhat, Vaibhav Shukla, et al.
Free Radical Biology and Medicine (2023) Vol. 201, pp. 1-13
Closed Access | Times Cited: 7
Fatty Acid Synthase: A Key Driver of Ovarian Cancer Metastasis and a Promising Therapeutic Target
Nuha Ahmad, Safwan Moton, Shilpa Kuttikrishnan, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155465-155465
Closed Access
Nuha Ahmad, Safwan Moton, Shilpa Kuttikrishnan, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155465-155465
Closed Access
Fatostatin promotes anti-tumor immunity by reducing SREBP2 mediated cholesterol metabolism in tumor-infiltrating T lymphocytes
Lei Zhu, Yilin Shi, Zhelong Feng, et al.
Research Square (Research Square) (2023)
Open Access
Lei Zhu, Yilin Shi, Zhelong Feng, et al.
Research Square (Research Square) (2023)
Open Access
